Page 2,713«..1020..2,7122,7132,7142,715..2,7202,730..»

Whole genome sequencing reveals, 'each child with autism is like a snowflake'

Posted: Published on January 26th, 2015

Results of the largest autism study to use whole genome sequencing suggest that no two autism cases are the same, even if they come from the same family. The study, published online Monday in the journal Nature Medicine, shows that there is a large genetic diversity in autism. It also underscores the need to do whole genome sequencing on patients, Dr. Stephen Scherer from Toronto's Hospital for Sick Children said in a statement. "We already knew that there are many differences between autism cases, but our recent findings firmly nail that down," he said. "It shows that a full assessment of each individual's genome is needed to determine how to best use knowledge of their own genetic makeup for autism treatment." For the study, researchers analyzed the DNA of 85 different families, each with two children with autism. Whole genome sequencing technology was used to detect any genetic mutations in the children. Scherer said the results showed that no two autism cases are the same, even if they come from the same family. "We believe each child with autism is like a snowflake; one is unique from another. Surprisingly, our research found that in more cases than not, even siblings … Continue reading

Comments Off on Whole genome sequencing reveals, 'each child with autism is like a snowflake'

Google Cloud Hosts 1,000 Genomes Uploaded By Autism Researchers, Advancing Science Through Data Storage

Posted: Published on January 26th, 2015

Scientists are leveraging cloud services provided by Google and other companies to streamline and share massive amounts of data generated by sequencing the human genome. The hope is that the increased power and speed of cloud services will accelerate research and increase opportunities for advances in medicine and other fields. For example, a thousand genomes of people who fall within the autism spectrum were uploaded to Googles servers Monday as part of a new projectsponsored by the nonprofit Autism Speaks. The data dump represents the first of 10,000 genomes that will eventually be stored in the companys cloud and shared among autism specialists. The funders of the project, known as Mssng, hope researchers will use the trove of genomes to enable earlier diagnosis, develop targeted treatments or even find a cure for the disorder thought to have at least some basis in genetics. Mssng is the latest in a series of genome-based projects that use cloud storage technology to advance science. Through these initiatives, cloud storage technology has proven to be a boon for both companies and scientists. Worldwide, cloud services make up a $45.7 billion industry,according to analystsat International Data Corp. Google has welcomed researchers by creating theGoogle Genomicsplatform … Continue reading

Comments Off on Google Cloud Hosts 1,000 Genomes Uploaded By Autism Researchers, Advancing Science Through Data Storage

UTMB offers latest treatment for stroke victims

Posted: Published on January 26th, 2015

PRESS RELEASE GALVESTON The University of Texas Medical Branch offers a new minimally invasive procedure to remove blood clots that has been shown to help patients better recover from a stroke. The procedure currently only is available in about half of the advanced stroke centers in the U.S. and UTMB is the only stroke facility in Galveston County that offers this procedure. A recent study in the New England Journal of Medicine found that the procedure, called an intra-arterial treatment, is significantly more effective than intravenous drugs that dissolve clots. The study, conducted in the Netherlands, found that the procedure was about twice as likely to restore mobility and functional independence compared to the clot-breaking drugs. In fact, the results were so promising that four clinical trials of the procedure being conducted across the globe, including the U.S., were halted and interim results of those trials also were very positive. At UTMB, we have seen how using intra-arterial treatment can change the course of a patients life for the better, said Dr.Venkata Dandamudi, assistant professor of neurology, neurosurgery and radiology. With intra-arterial treatment like stent based clot retrieval and suction-based catheter treatment, more patients are able to not only survive … Continue reading

Comments Off on UTMB offers latest treatment for stroke victims

Virtual reality helps boost memory in stroke patients

Posted: Published on January 26th, 2015

Melbourne, Jan 26: Scientists have developed a new treatment which uses a 3D virtual reality environment to improve the memory of stroke patients. Researchers from the University of Canterbury, New Zealand, have developed the treatment method which improves prospective memory in stroke patients. These tests using a virtual reality environment for stroke patients to practise their cognitive skills clearly work, said Professor Tanja Mitrovic. Prospective memory, or remembering to perform actions in the future, is of crucial importance for everyday life. This kind of memory is often impaired in stroke survivors and can interfere with independent living, as it can result in forgetting to take medication, or remember something they had to do. It is a complex cognitive ability, which requires coordination of multiple cognitive abilities: spatial navigation, retrospective memory, attention and executive functioning. We have developed a computer-based treatment based on visual imagery which teaches participants how to remember time and event-based prospective memory tasks. After the treatment, participants practiced their skills using videos first and later in a 3D virtual reality environment, Mitrovic said. The study included 15 stroke survivors and each participant had 10 individual sessions spread over 10 weeks. Read the rest here: Virtual reality helps … Continue reading

Comments Off on Virtual reality helps boost memory in stroke patients

Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson’s Disease – Video

Posted: Published on January 26th, 2015

Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson's Disease On Thursday, January 8, RYTARY, an extended release formulation of carbidopa/levodopa, was approved by the US Food and Drug Administration (FDA) for the trea... By: parkinsonsdiseasefdn … Continue reading

Posted in Parkinson's Treatment | Comments Off on Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson’s Disease – Video

Ipsen: Treatment With Dysport Improved Muscle Tone In Cerebral Palsy Children

Posted: Published on January 26th, 2015

By RTT News, January 26, 2015, 01:42:00 AM EDT (RTTNews.com) - Ipsen SA ( IPSEY ) Monday reported topline results for two double-blind phase III studies of Dysport (abobotulinumtoxinA) in Pediatric Lower Limb or PLL spasticity in children with cerebral palsy and in Adult Lower Limb or ALL spasticity in patients who had experienced a stroke or traumatic brain injury. In the PLL phase III study, conducted in children with hemiparetic or diplegic cerebral palsy, treatment with Dysport showed a statistically significant response compared to placebo in the improvement of muscle tone, as measured by the Modified Ashworth Scale or MAS, which was the primary endpoint. It also showed a statistically significant overall benefit versus placebo, as measured by the Physician Global Assessment or PGA, which was the first secondary endpoint. In the ALL phase III study, conducted in hemiparetic patients who had experienced a stroke or traumatic brain injury, treatment with Dysport at the dose of 1500U showed a statistically significant response versus placebo in the improvement of muscle tone. The safety profile observed in the studies was consistent with the known safety profile of Dysport in these indications. For comments and feedback: contact editorial@rttnews.com http://www.rttnews.com Read more from … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Ipsen: Treatment With Dysport Improved Muscle Tone In Cerebral Palsy Children

MS research company, Carman CEO in question

Posted: Published on January 26th, 2015

Just under four years ago, Carman resident Jolene Stevenson travelled to India to undergo Liberation Therapy in the hopes that it would cure her MS. They were thinking that the Liberation treatment is the cure, she remembered. So if it worked there wouldnt be any more symptoms of MS. The treatment and travel costs added up to about $17,000 and the Carman community held a fundraiser to help Stevenson with the expenses, bringing in over $10,000 to help support her trip. Stevensons treatment was arranged through Regenetek Research and she paid the fee through CliniCard Inc. - both companies owned by another Carman resident,DougBroeska,whose credentials came into question earlier this month. Other media organizations have reported that Broeska both fabricated his credentials and overstated the results of the Combination Therapy MS treatment for which he recruited patients. Regenetek Inc. and CliniCard are both located at 1213 Chevrier Boulevard in Winnipeg. Broeskapreviously owned and operated a lumber company called Hardwood Forest Products at the same address. Broeska stated on his LinkedIn profile (now removed) that he graduated with a Bachelor of Science and a Ph.D. from the University of Manitoba, but the university registrars office told the Valley Leader there is … Continue reading

Posted in MS Treatment | Comments Off on MS research company, Carman CEO in question

Low Testosterone in Men — An American Epidemic

Posted: Published on January 26th, 2015

SOURCE: LIFEFORCE Medical Institute Dr. Mark Rosenbloom, Founder of LIFEFORCE Medical Institute in Chicago, and Renowned Expert in Age Management and Hormone Replacement Therapy, Was Prominently Featured in the Current Jan-Feb Issue of Playboy Magazine for His Expertise on the Subject of Testosterone Replacement Therapy for Men NORTHBROOK, IL--(Marketwired - January 26, 2015) - Alarming scientific evidence recently presented in a well-researched report in Playboy Magazine shows American men 35 to 70 years old are plagued with testosterone levels significantly lower than their fathers before them. Dr. Mark Rosenbloom, founder of LIFEFORCE Medical Institute in Chicago, was referenced and quoted by Playboy throughout their January/February, 2015 cover story entitled "How Low T Became the Disease du Jour." A study cited by Playboy from the Journal of Clinical Endocrinology & Metabolism shows a 22 percent drop in male testosterone levels since the late 1980s. Some scientists blame record low levels of testosterone on a combination of environmental factors such as phytoestrogens in plants like soy, flame retardants in computers and furniture, and BPA in plastic containers. Researchers say Low T could be responsible for a host of problems such as hypertension, high cholesterol, obesity, low sex drive, low energy levels and … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Low Testosterone in Men — An American Epidemic

Novo Nordisk Receives FDA Approval for Norditropin FlexPro 30 mg/3.0 mL for Patients with Growth Hormone Disorders

Posted: Published on January 26th, 2015

PLAINSBORO, N.J., Jan. 26, 2015 /PRNewswire/ --Novo Nordisk announced today the U.S. Food and Drug Administration (FDA) approval of Norditropin (somatropin [rDNA origin] injection) FlexPro 30 mg/3.0 mL, a prefilled injection pen for patients with growthhormone-related disorders. The FlexPro 30 mg/3.0 mL device complements the existing portfolio of Norditropin FlexPro products available in 5 mg/1.5 mL, 10 mg/1.5 mL and 15 mg/1.5 mL pens. "Novo Nordisk is committed to advancing growth hormone delivery devices with patients in mind," said Eddie Williams, senior vice president, Biopharmaceuticals, Novo Nordisk. "This approval marks another option for patients who may need higher doses of treatment." The availability of four different strengths of Norditropin FlexPro enhances physicians' ability to better address the unique needs of appropriate patients on treatment. Each Norditropin FlexPro pen is prefilled with Norditropin, and is color coded to differentiate the various strengths. Novo Nordisk plans to make Norditropin FlexPro 30 mg/3.0 mL available by April 2015. Visit http://www.norditropin.comfor more information on Norditropin. Indications and UsageWhat is Norditropin (somatropin [rDNA origin] injection)? Norditropin is a prescription medicine that contains human growth hormone and is used to treat: Important Safety InformationWho should not use Norditropin?Do not use Norditropin if: What should I tell … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Novo Nordisk Receives FDA Approval for Norditropin FlexPro 30 mg/3.0 mL for Patients with Growth Hormone Disorders

It's not just hot flushes – women's hormones also trigger asthma

Posted: Published on January 26th, 2015

Sarah Broom, 42, was suddenly struggling to control her asthma The nurse from Sutton Coldfield, West Midlands, rarely had symptoms Her condition was controlled with her preventer and reliever inhalers But tests showed levels of airflow dropped shortly before every period By Cara Lee for the Daily Mail Published: 19:41 EST, 26 January 2015 | Updated: 20:34 EST, 26 January 2015 Sarah Broom, 42, had no idea why she was suddenly struggling to control her asthma symptoms Sarah Broom had no idea why she was suddenly struggling to control her asthma symptoms. The nurse had been diagnosed with the condition in 2006, after developing a tickly cough and wheeze. But once diagnosed, she rarely had asthma symptoms as her condition was controlled with her preventer and reliever inhalers. Then, in March 2011, she had an asthma attack and was admitted to hospital after going to A&E. 'I was wheezing, coughing a lot at night and couldn't breathe properly - but, unusually, my reliever inhaler wasn't helping,' says Sarah, 42, from Sutton Coldfield, West Midlands. Doctors gave her stronger medications, including a nebuliser, which creates a mist of higher-dose medicine breathed in through a mask, and steroid tablets to reduce the … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on It's not just hot flushes – women's hormones also trigger asthma

Page 2,713«..1020..2,7122,7132,7142,715..2,7202,730..»